The 2026 Biosecurity Blind Spot

The 2026 Biosecurity Blind Spot:
Why a Lower-Ranked Risk May Be Harder to See

The World Economic Forum’s 2026 risk survey ranks biological, chemical or nuclear weapons or hazards only 28th over the next two years and 20th over 10 years. Yet that low ranking should not be read as low consequence: it reflects relative expert perception amid immediate geoeconomic confrontation, conflict and information threats—not an assurance that accidental laboratory releases or deliberate biological events are well monitored or easily contained.

Executive comparison

The WEF defines the relevant biosecurity category as the intentional or accidental release of biological, chemical, nuclear or radiological hazards causing loss of life, destruction or international crisis. Its examples explicitly include accidents at, or sabotage of, biolaboratories and deliberate or accidental weapons releases. This is a broader category than biosecurity alone, but it is the WEF indicator most directly applicable to accidental laboratory incidents and intentional biological release scenarios.

Risk category	WEF risk	Severity rank: 2 years	Severity rank: 10 years	What drives the outlook
Geopolitical	Geoeconomic confrontation	1	19	Sanctions, tariffs, technology controls, capital restrictions and supply-chain weaponization are viewed as acute near-term sources of systemic disruption.
Geopolitical	State-based armed conflict	5	Outside overall top 10	Conflict remains a major near-term concern and can directly threaten laboratories, health infrastructure and pathogen security.
AI / technology	Misinformation and disinformation	2	4	It is already degrading public discourse, institutional trust and crisis response; its threat is expected to remain severe over the decade.
AI / technology	Adverse outcomes of AI technologies	30	5	WEF respondents see AI risk as the largest upward move of any risk: comparatively distant in the next two years, but among the most severe by 2036.
Environment	Extreme weather events	4	1	Near-term disruption is already material, but cumulative exposure makes it the foremost 10-year risk.
Environment	Biodiversity loss and ecosystem collapse	26	2	It is comparatively deprioritized in the immediate horizon but becomes a core long-term systemic threat.
Environment	Critical change to Earth systems	24	3	Respondents expect large cumulative and potentially irreversible consequences over a decade. weforum
Biosecurity-related	Biological, chemical or nuclear weapons or hazards	28	20	Perceived as less likely or less salient than current crises, despite potentially catastrophic tail risk and difficult attribution. scribd

The ranking pattern is the story. In two years, WEF respondents focus on conflicts, economic coercion and information disruption. In 10 years, environmental threats dominate, while adverse AI outcomes move from 30th to 5th. The biohazard category improves only modestly, from 28th to 20th, remaining outside the top tier in both

That relative placement does not mean that an intentional biological event or laboratory accident would have modest consequences. It means experts assess it as less likely to be the most severe global risk within the specified horizon than the risks ranked above it. Risk rankings combine perceptions of likelihood, salience and systemic impact; they should not be used as a preparedness budget formula.

The new reveal: visibility is part of biosecurity

The uncomfortable distinction is this: many leading risks are observable before they become catastrophic; biological incidents may not be.

A tariff announcement, troop movement, extreme-weather forecast or cyberattack often produces early indicators that markets, governments and businesses can observe. A biological release can begin as unexplained illness, a laboratory exposure, an animal-health event or a contaminated supply chain. Whether it was accidental, deliberate or natural may initially be unclear.

WHO warns that a biological attack can mimic a naturally occurring event, complicating public-health assessment and response. It also notes that agents capable of secondary transmission can lead to epidemics, while high-threat pathogen laboratories may become targets during conflict.

This produces a monitoring asymmetry:

Risk	Typical early-warning signal	Main obstacle to coordinated response	Consequence of delayed attribution
Geoeconomic confrontation	Policy announcements, trade measures, capital controls, supply-chain disruption	Political bargaining and retaliatory incentives	Economic losses and fragmentation can accelerate, but the action is usually visible
State-based armed conflict	Military mobilization, intelligence, kinetic incidents	Sovereignty, security secrecy and adversarial intent	Escalation and spillover, though the conflict itself is often observable
AI misuse or adverse outcomes	Model deployments, incidents, data misuse, synthetic media, cyber events	Rapid innovation, proprietary systems and uneven regulation	Harm can spread quickly, particularly through information systems
Extreme weather	Meteorological data, seasonal forecasts, climate modelling	Financing, adaptation capacity and political willingness	Physical damage, displacement and infrastructure disruption
Laboratory accident or intentional biological release	Laboratory incident reports, clinical surveillance, genomic signals, animal and environmental surveillance	Underreporting, biosafety gaps, sovereignty, secrecy and attribution uncertainty	Delayed containment, loss of trust, and possibly uncontrolled cross-border spread

The implication for decision-makers is significant. Biosecurity is not merely about preventing an event within a laboratory. It is a system-of-systems challenge connecting laboratory practices, workforce culture, pathogen access controls, clinical surveillance, veterinary intelligence, wastewater and environmental monitoring, logistics, emergency communications and international information-sharing.

Contrast framing: a low rank is not a low duty

The old interpretation of a risk register is: fund what ranks highest. The better interpretation is: distinguish between frequent, visible threats and low-frequency, high-consequence threats whose detection systems deteriorate when cooperation breaks down.

The WEF’s report describes 2026 as an “age of competition,” in which cooperative mechanisms are weakening, governments are retreating from multilateral frameworks, and trust, transparency and respect for the rule of law are under pressure. It says 68% of surveyed respondents expect a more fragmented, multipolar order over the next decade, while only 6% expect a reinvigorated unipolar, rules-based order.

This matters disproportionately for biosecurity for four reasons.

1. Biological incidents require trusted reporting

Laboratory-associated infections, containment failures, theft, loss or misuse of sensitive biological agents require credible reporting and investigation. WHO guidance recommends incident reporting systems that cover accidental and intentional exposures, with particular attention to the loss, theft or misuse of security-sensitive biological agents.

At the facility and national level, transparent reporting creates learning: what occurred, how it was detected, what barriers failed and what controls must change. Across borders, however, incident disclosure can carry reputational, commercial, political and security costs. In a lower-trust geopolitical environment, the incentive to delay, narrow or politicize disclosure rises.

That is unlike extreme weather, where the meteorological event cannot credibly be concealed from neighbouring states, insurers, satellite systems and affected populations. It also differs from tariffs or sanctions, which are usually overt policy instruments. Biological events often start with ambiguous signals and can be obscured by the normal background of respiratory, gastrointestinal or animal disease.

2. Attribution matters more than it first appears

For an outbreak, the immediate public-health response should not wait for certainty about intent. WHO’s approach focuses on public-health consequences regardless of whether the event is deliberate or naturally occurring.

But attribution still matters for diplomacy, criminal investigation, deterrence, sanctions, intelligence cooperation and restoration of public trust. Declining multilateralism makes collective attribution harder because the same data: clinical samples, genomic sequences, laboratory records, exposure histories and epidemiological patterns, may be treated as contested evidence rather than shared evidence.

The Biological and Toxin Weapons Convention, or BWC, is central but constrained. Expert analysis from the Nuclear Threat Initiative argues that the treaty remains severely weakened by the absence of a workable verification mechanism and that its voluntary confidence-building measures do not provide a legally enforceable system for collecting evidence for or against alleged non-compliance. VERTIC similarly notes that the BWC lacks the dedicated international verification organization, inspectorate and monitoring body that exist for chemical weapons under the Organisation for the Prohibition of Chemical Weapons.

This creates a critical difference from several other risk categories:

• Climate and extreme weather benefit from globally distributed observational infrastructure, established scientific assessment and comparatively mature data-sharing norms.
• Cyber insecurity is difficult to attribute, but firms, governments and security vendors operate dense technical monitoring networks, while incidents can generate machine-readable evidence at scale.
• Geoeconomic confrontation is often conducted through publicly documented measures such as tariffs, export controls, sanctions and investment restrictions.
• Biological incidents depend more heavily on sovereign cooperation, local diagnostic capacity, honest incident reporting and access to sensitive facilities or data.
  

3. Fragmentation can create weak links

A biological risk system is only as strong as its detection, containment and reporting capacity across the relevant network. A high-containment facility may have excellent internal controls, yet still be connected to suppliers, waste handling, transport providers, contract research organizations, hospitals, animal-health systems and cross-border sample flows.

WHO identifies biosafety and biosecurity as among the weakest core capacities found through International Health Regulations monitoring and evaluation. It emphasizes strengthening surveillance, laboratory biosafety and biosecurity, cross-sector coordination, risk assessment and contingency planning.

In a fragmented world, states may pursue national self-reliance in strategic biotechnology, restrict data flows, classify capabilities, restrict researchers or treat biological information as a strategic asset. Some restrictions can be legitimate particularly for dual-use knowledge, sensitive pathogen data and advanced biological tools. But unmanaged fragmentation can undermine the very cross-border surveillance and verification needed to detect an accidental or intentional release early.

4. AI magnifies both defence and exposure

WEF’s two-horizon ranking for AI is striking. “Adverse outcomes of AI technologies” ranks 30th over two years but 5th over 10 years, the largest upward movement among the 33 risks surveyed.

For biosecurity, AI is a dual-use accelerator:

• It can strengthen surveillance through anomaly detection, outbreak forecasting, sequence analysis, laboratory quality management and triage of scientific literature.
• It can also broaden access to information and capabilities relevant to harmful biological activity, increase the pace of scientific design cycles, and overwhelm institutions with synthetic misinformation during a health event.
  

The key is not to assume that AI makes biological misuse inevitable. It does not. Rather, it raises the premium on controls that pair access with accountability: screening, red teaming, audit trails, responsible model governance, secure-by-design laboratory workflows and trained human review.

A 2026 peer-reviewed analysis of synthetic biology, AI and biosecurity identifies inadequate risk awareness, insufficient training, weak monitoring of access authorization at high-security laboratories, and lack of verification instruments under the BWC among significant vulnerabilities. It recommends training, monitoring, agile governance, red-team exercises and stronger international treaty arrangements.

Urgency: the risk architecture is changing now

The immediate challenge is not that biosecurity has suddenly become the highest-ranked WEF risk. It is that the operating environment required to manage it is degrading while biotechnology and AI capabilities diffuse.

WEF respondents are more pessimistic in the near term about geopolitical risks: close to two-thirds view the geopolitical outlook as turbulent or stormy over two years. Over 10 years, nearly three-quarters view the environmental outlook that way, making it the most pessimistic category.

That means leaders should avoid a false choice between climate, AI, geopolitical and biosecurity investment. The risks interact:

• Armed conflict can damage health systems and threaten facilities holding dangerous pathogens.
• Geoeconomic fragmentation can disrupt diagnostics, protective equipment, vaccine inputs, scientific equipment, data flows and cross-border outbreak cooperation.
• Misinformation can weaken adherence to health guidance and complicate investigation during an outbreak.
• AI can strengthen biological surveillance and emergency operations while creating new governance and misuse challenges.
• Extreme weather can stress public-health capacity, displace populations, disrupt supply chains and increase disease-control complexity.

The WEF itself cautions against treating environmental risks as less serious merely because their short-term ranking has slipped. The organisation argues that the shift reflects competition for attention from immediate shocks, not a reduction in the underlying exposure. The same analytical discipline should be applied to biological hazards: lower survey rank should not be confused with a lower need for resilient preparedness.

What leaders should do

A proportionate response does not require treating every laboratory as a suspected threat or blocking legitimate science. It requires making safe science, early detection and credible cooperation more resilient than the political pressures pulling institutions apart.

Build a biosecurity control tower

Organizations that operate, fund, insure, supply or depend on life-science capabilities should map their biosecurity exposure across:

• Laboratory locations, containment levels and critical agents.
• Outsourced research, manufacturing and sample-transfer partners.
• Access authorization, personnel reliability, training and offboarding.
• Incident-reporting channels, near-miss reporting and protected escalation routes.
• Dependencies on diagnostic reagents, PPE, cold-chain logistics, cloud infrastructure and specialized equipment.
• Connections to public-health, animal-health, food-safety and law-enforcement partners.
  

The objective is not a static compliance inventory. It is a live view of where detection, reporting or containment could fail.

Treat reporting as a learning system

A strong programme makes it easy to report, investigate and learn from near misses before they become external events. WHO guidance is explicit: incidents should be reported and investigated promptly, with written records maintained under national requirements.

Practical measures include:

• Establishing non-punitive, confidential escalation mechanisms for biosafety and biosecurity concerns.
• Defining materiality thresholds and timelines for management, regulator and cross-border notification.
• Running independent root-cause reviews after exposures, losses, containment deviations and security anomalies.
• Testing whether vendors and contract laboratories meet the same reporting and corrective-action standard.
• Separating the need for transparent incident learning from the need to protect genuinely sensitive security information.
  

Design for attribution uncertainty

Response plans should be built around the first operational question: “How do we contain harm?” rather than the first political question “Who caused this?”

For a suspicious outbreak or possible laboratory event, organizations should pre-agree:

• Who can activate emergency surveillance and business-continuity procedures.
• What evidence must be preserved and how chain of custody will be maintained.
• How clinical, environmental, laboratory and supply-chain data will be integrated.
• Which authorities receive notice and how communication will be coordinated.
• What messages can be issued before intent is established.
  

This approach aligns with WHO’s consequence-based preparedness model for deliberate biological events.

Keep international links operational

Declining multilateralism does not eliminate the need for cooperation; it makes practical, trusted networks more valuable.

Leaders should support:

• Participation in recognized outbreak-alert, laboratory-quality and sectoral information-sharing networks.
• Cross-border exercises involving public health, veterinary, food, transport, cyber and security stakeholders.
• Standardized incident taxonomies and interoperable reporting formats.
• Secure mechanisms for sensitive information exchange, so states and institutions do not have to choose between secrecy and unsafe silence.
• Scientific partnerships that preserve responsible access and accountability rather than indiscriminate openness.
  

The public-policy priority is to strengthen the BWC’s practical capacity for confidence, transparency and verification while recognizing legitimate national-security concerns. The present gap is structural: the BWC lacks a dedicated verification and compliance system, so trust and voluntary cooperation carry unusually heavy weight.

The opposing view

There is a reasonable opposing argument: biosecurity should not be elevated above the risks already causing visible, global damage. WEF’s rankings show that geoeconomic confrontation, conflict, misinformation, cyber insecurity and extreme weather are more urgent or more severe in the eyes of surveyed experts. Redirecting scarce public funding toward a relatively low-ranked biohazard category could weaken immediate resilience against threats already materializing.

That argument has force. Decision-makers should not abandon climate adaptation, conflict prevention, cybersecurity, information integrity or economic resilience for speculative scenarios.

But the counterargument is stronger when framed correctly. Biosecurity investment is not a separate, hypothetical insurance policy. The core capabilities/ safe laboratories, incident reporting, disease surveillance, genomic and diagnostic capacity, cross-sector coordination, trusted communications, resilient supply chains and international alert networks also improve readiness for naturally occurring outbreaks, food and animal-health events, deliberate attacks and disruptions amplified by climate or conflict.

The best strategy is therefore portfolio resilience, not risk-category competition. Fund visible current harms, while preserving the detection and cooperation infrastructure that prevents a low-probability biological event from becoming a high-consequence global failure.

How PAD US can help

PAD US can help organizations move from abstract concern to an operating model for converging risk. This includes facilitating executive risk workshops that connect geopolitical, AI, environmental and biosecurity exposures; mapping critical dependencies across laboratories, suppliers, data and response partners; designing board-level indicators and incident-escalation protocols; and developing scenario exercises for ambiguous biological incidents, including misinformation and supply-chain disruption. For decision-makers, the practical value lies in translating global-risk signals into governance, resilience investment and tested response capability.

Bibliography

1. World Economic Forum. The Global Risks Report 2026: Digest. World Economic Forum.
2. World Economic Forum. Global Risks 2026–2036: The Age of Competition. World Economic Forum.
3. World Economic Forum. What the Global Risks Report 2026 Really Says About the Urgency of Environmental Threats. World Economic Forum.
4. World Health Organization. Safeguarding Biosafety and Biosecurity in Laboratories. WHO.
5. World Health Organization. Laboratory Biosecurity Guidance. WHO IRIS.
6. World Health Organization. Implementing Regulatory Requirements for Biosafety and Biosecurity. WHO IRIS.
7. Nuclear Threat Initiative. Creating a Verification Protocol for the Biological Weapons Convention. NTI.
8. Verification Research, Training and Information Centre. Verification and the Biological Weapons Convention. VERTIC.
9. Sabra, D. M., Frieß, J. L., Giese, B. and Jeremias, G. “Improving Governance in the Age of Synthetic Biology, Artificial Intelligence, and Diverging Threats.” Frontiers in Bioengineering and Biotechnology, 2026. Frontiers.

Researched and drafted with AI assistance, edited and fact-checked by the author. Illustration: AI-generated.